An artificial peptide inhibits autophagy through calcineurin-TFEB pathway.

Autophagy-lysosome pathway Calcineurin Inhibitor Pep3 Transcription factor EB

Journal

Biochimica et biophysica acta. Molecular cell research
ISSN: 1879-2596
Titre abrégé: Biochim Biophys Acta Mol Cell Res
Pays: Netherlands
ID NLM: 101731731

Informations de publication

Date de publication:
29 Sep 2024
Historique:
received: 01 07 2024
revised: 18 09 2024
accepted: 20 09 2024
medline: 3 10 2024
pubmed: 3 10 2024
entrez: 1 10 2024
Statut: aheadofprint

Résumé

We previously reported that a bioactive peptide (pep3) can potently inhibit the enzyme activity of purified calcineurin (CN). In this paper, we further demonstrate that transfected pep3 can strongly inhibit CN enzyme activity in HEK293 cells. Transcription factor EB (TFEB) plays an important role in the autophagy-lysosome pathway (ALP) as one of the substrates of CN, so we study the effect of pep3 on the CN-TFEB-ALP pathway. Pep3 can significantly inhibit the mRNA levels of the TFEB downstream genes and the expression of the autophagy-associated proteins, and autophagy flux in HEK293 cells. We also validated the inhibitory effect of pep3 on autophagy in mice. These findings may provide a new idea for discovering more CN inhibitors and autophagy inhibitory drugs.

Identifiants

pubmed: 39353470
pii: S0167-4889(24)00196-4
doi: 10.1016/j.bbamcr.2024.119853
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119853

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest We confirm that this work is original and not written by AI, nor has it been published elsewhere. All authors have no conflicts of interest that need to be disclosed. .

Auteurs

Yumeng Yang (Y)

Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China.

Yanan Li (Y)

Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China.

Hanxiao Shang (H)

Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 111016, China.

Yueyang Liu (Y)

Shenyang Key Laboratory of Vascular Biology, Science and Research Center, Department of Pharmacology, Shenyang Medical College, Shenyang, China.

Wenying Li (W)

Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China.

Limin Chen (L)

Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China.

Na Cheng (N)

Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China.

Yuchen Zhang (Y)

Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China.

Nan Zhang (N)

Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China.

Yanxia Yin (Y)

Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China.

Li Tong (L)

Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China.

Zhimei Li (Z)

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing 100050, China. Electronic address: lizm1211@163.com.

Jingyu Yang (J)

Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 111016, China. Electronic address: yangjingyu@syphu.edu.cn.

Jing Luo (J)

Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China. Electronic address: luojing@bnu.edu.cn.

Classifications MeSH